ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program

[1]  P. Ness,et al.  Red cell, platelet, and white cell antigens , 2018 .

[2]  H. Yaish,et al.  Neonatal nonimmune hemolytic anemia , 2017, Current opinion in pediatrics.

[3]  Hildur Harðardóttir,et al.  Mótefni bundin við rauðkorn nýbura; orsakir og klínískar afleiðingar - Tilfelli greind í Blóðbankanum 2005-2012 , 2016 .

[4]  S. Perkins,et al.  Clinical utility of next‐generation sequencing in the diagnosis of hereditary haemolytic anaemias , 2016, British journal of haematology.

[5]  R. Wong,et al.  Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia , 2016, Acta paediatrica.

[6]  D. Paro-Panjan,et al.  The role of carboxyhemoglobin measured with CO-oximetry in the detection of hemolysis in newborns with ABO alloimmunization , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[7]  M. Bluth,et al.  Neonatal BO Incompatibility Is Associated With a Positive Cord Blood Direct Antiglobulin Test in Infants of Black Ethnicity , 2015, Journal of pediatric hematology/oncology.

[8]  J. Prchal,et al.  Measuring End-Tidal Carbon Monoxide of Jaundiced Neonates in the Birth Hospital to Identify Those with Hemolysis , 2015, Neonatology.

[9]  A. Ogbenna,et al.  Estimating the Risk of ABO Hemolytic Disease of the Newborn in Lagos , 2015, Journal of blood transfusion.

[10]  H. Yaish,et al.  Hemolytic Disorders Causing Severe Neonatal Hyperbilirubinemia. , 2015, Clinics in perinatology.

[11]  A. Malamitsi‐Puchner,et al.  Importance of Direct Antiglobulin Test (DAT) in Cord Blood: Causes of DAT (+) in a Cohort Study. , 2015, Pediatrics and neonatology.

[12]  W. Savage,et al.  Hemolysis from ABO Incompatibility. , 2015, Hematology/oncology clinics of North America.

[13]  A. Ogbenna,et al.  Prevalence of anti-A and anti-B hemolysis among blood group O donors in Lagos. , 2015, Nigerian journal of clinical practice.

[14]  D. Stevenson,et al.  Bilirubin production and hour-specific bilirubin levels , 2015, Journal of Perinatology.

[15]  J. Prchal,et al.  End-tidal carbon monoxide as an indicator of the hemolytic rate. , 2015, Blood cells, molecules & diseases.

[16]  V. Bhutani,et al.  The clinical syndrome of bilirubin-induced neurologic dysfunction. , 2015, Seminars in fetal & neonatal medicine.

[17]  D. Stevenson,et al.  Direct Antiglobulin Titer Strength and Hyperbilirubinemia , 2014, Pediatrics.

[18]  D. Stevenson,et al.  End-tidal carbon monoxide and hemolysis , 2014, Journal of Perinatology.

[19]  H. Yaish,et al.  Causes of hemolysis in neonates with extreme hyperbilirubinemia , 2014, Journal of Perinatology.

[20]  T. Pysher,et al.  Neonatal Death Suspected To Be From Sepsis Was Found To Be Kernicterus With G6PD Deficiency , 2013, Pediatrics.

[21]  S. Suchitha,et al.  Hemolytic Disease of the Newborn Due to Anti-c Isoimmunization: A Case Report , 2013, Indian Journal of Hematology and Blood Transfusion.

[22]  J. Prchal,et al.  Acute Kernicterus in a Neonate With O/B Blood Group Incompatibility and a Mutation in SLC4A1 , 2013, Pediatrics.

[23]  M. J. Maisels,et al.  Routine blood typing and DAT in infants of group O mothers , 2013, Journal of Perinatology.

[24]  M. B. Ross,et al.  Hemolytic disease of the fetus and newborn , 2013 .

[25]  V. Shah,et al.  Incidence of Chronic Bilirubin Encephalopathy in Canada, 2007–2008 , 2012, Pediatrics.

[26]  A. Zanella,et al.  Six children with pyruvate kinase deficiency from one small town: molecular characterization of the PK-LR gene. , 2011, The Journal of pediatrics.

[27]  S. Bennett,et al.  Reference Ranges for Blood Concentrations of Nucleated Red Blood Cells in Neonates , 2010, Neonatology.

[28]  D. Stevenson,et al.  Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates. , 2010, The Journal of pediatrics.

[29]  J. Watchko.  Hyperbilirubinemia in African American neonates: clinical issues and current challenges. , 2010, Seminars in fetal & neonatal medicine.

[30]  K. Roy,et al.  Severe hydrops in the infant of a Rhesus D-positive mother due to anti-c antibodies diagnosed antenatally: a case report , 2010, Journal of medical case reports.

[31]  Erick Henry,et al.  Reference Ranges for Hematocrit and Blood Hemoglobin Concentration During the Neonatal Period: Data From a Multihospital Health Care System , 2009, Pediatrics.

[32]  V. Bhutani,et al.  Clinical report from the pilot USA Kernicterus Registry (1992 to 2004) , 2009, Journal of Perinatology.

[33]  A. Stark,et al.  Management of Jaundice and Prevention of Severe Neonatal Hyperbilirubinemia in Infants ≥35 Weeks Gestation , 2008, Neonatology.

[34]  R. Clark,et al.  Hydrops Fetalis: A Retrospective Review of Cases Reported to a Large National Database and Identification of Risk Factors Associated With Death , 2007, Pediatrics.

[35]  R. Christensen,et al.  The Effect of Instituting a Prehospital-Discharge Newborn Bilirubin Screening Program in an 18-Hospital Health System , 2006, Pediatrics.

[36]  W. Benjamin,et al.  Severe hemolytic disease of the newborn in a group B African-American infant delivered by a group O mother. , 2006, Annals of clinical and laboratory science.

[37]  S. Joy,et al.  Management of Pregnancies Complicated by Anti-E Alloimmunization , 2003, Obstetrics and gynecology.

[38]  W. Judd.  Practice guidelines for prenatal and perinatal immunohematology, revisited , 2001, Transfusion.

[39]  S. Hannam,et al.  Hydrops fetalis due to ABO incompatibility , 1998, Archives of disease in childhood. Fetal and neonatal edition.

[40]  R. Herzlinger,et al.  Fetal ascites associated with ABO incompatibility: case report and review of the literature. , 1996, American journal of obstetrics and gynecology.

[41]  J. Watchko,et al.  Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. , 1994, The Journal of pediatrics.

[42]  D. Sherer,et al.  SEVERE FETAL HYDROPS RESULTING FROM ABO INCOMPATIBILITY , 1991, Obstetrics and gynecology.

[43]  V. Shah,et al.  Hydrops Fetalis Due to ABO Incompatibility , 1988, Clinical pediatrics.

[44]  Monoghan Wp,et al.  ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases. , 1980, American journal of clinical pathology.

[45]  J M Bowman,et al.  Rh erythroblastosis fetalis 1975. , 1975, Seminars in hematology.

[46]  Miller Df,et al.  FATAL ERYTHROBLASTOSIS FETALIS SECONDARY TO ABO INCOMPATIBILITY. REPORT OF A CASE. , 1963 .

[47]  H. Yaish,et al.  Reference intervals for reticulocyte parameters of infants during their first 90 days after birth , 2016, Journal of Perinatology.

[48]  B. Glader,et al.  Chapter 77 – Erythrocyte Disorders in Infancy , 2012 .

[49]  N. Bhatta,et al.  Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: a prospective cohort study. , 2009, Kathmandu University medical journal.

[50]  N. Ozbek,et al.  Fatal course of ABO hemolytic disease associated with hydrops in a twin pregnancy. , 2006, The Turkish journal of pediatrics.